Drugs / Oxygen gas

Trials 6 · a red edge is where a trial was stopped

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 21 trial
Phase 2 NCT05237505 Feb 2024 → Aug 2028 expected chronic obstructive pulmonary disease, obstructive sleep apnea syndrome University of California, San Diego Recruiting No outcome recorded
Phase 33 trials
Phase 3 NCT04990349 Jan 2022 → Nov 2023 cardiogenic shock Centre Hospitalier Universitaire de Besancon Completed No outcome recorded
Phase 3 NCT04003116 Jul 2019 → Apr 2022 pulmonary embolism Ministry of Health, Spain Completed No outcome recorded
Phase 3 NCT03369184 Jan 2018 → May 2019 coronary artery disorder Karolinska Institutet Terminated No outcome recorded
Phase not applicable2 trials
NCT03771534 Sep 2018 → Dec 2023 transposition of the great arteries The Hospital for Sick Children Completed No outcome recorded
NCT02344732 Oct 2013 → Oct 2014 corneal disorder Universiti Sains Malaysia Completed No outcome recorded
Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT04223050 Comparator Feb 2020 → Aug 2024 chronic obstructive pulmonary disease Esbjerg Hospital - University Hospital of Southern Denmark Terminated No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 7 sources stand behind the page.

FieldValueCited text
Known as Oxygen gas ClinicalTrials.gov intervention name — accepted as the source's own label NCT04223050
6

NCT05237505

NCT04990349

NCT03771534

NCT03369184

NCT02344732

NCT04003116

Route Other “systemic oxygen via simple face mask at 10 litres/min” NCT02344732